<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943477/" ref="ordinalpos=967&amp;ncbi_uid=5888500&amp;link_uid=PMC3943477" image-link="/pmc/articles/PMC3943477/figure/F3/" class="imagepopup">Figure 3. Developing <span class="highlight" style="background-color:">Pathway</span> Assays.  From: Case Study Approaches for Implementing the 2007 NRC Report "Toxicity Testing in the 21st Century: A Vision and A Strategy". </a></div><br /><div class="p4l_captionBody">The steps shown here constitute the process of assuring that pathway assay are fit for purpose, i.e., for identifying activity in a specific pathway, assessing the structure and dynamics of the overall signaling network, and providing computational systems biology pathway models to assist dose-response modeling of assay results and low-dose extrapolations. The process of pathway development is fundamental to their use as part of a testing suite for risk assessment, as shown in Figure 2.</div></div>